Both CD4+ and CD8+ T cells have the capacity to traverse the blood-brain barrier, thereby gaining entry to the brain and engaging in the modulation of central neuroinflammation, which in turn affects the progression of AD (Jorfi et al., 2023b). This evidence concerns the gene CD4 and Alzheimer disease.